Cargando…

Circulating growth arrest-specific protein 6 levels are associated with erythropoietin resistance in hemodialysis patients

Growth arrest-specific protein 6 (Gas6) works synergistically with erythropoietin (EPO) to increase the proliferation and maturation of erythroblasts. However, the role of Gas 6 levels on EPO resistance in hemodialysis (HD) patients remains unclear. Therefore, the objective of this study was the fir...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Miao-Pei, Chen, Chien-Wen, Chen, Jin-Shuen, Mao, Hung-Chung, Chou, Chu-Lin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2016
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4710623/ https://www.ncbi.nlm.nih.gov/pubmed/26788441 http://dx.doi.org/10.1186/s40064-016-1681-z

Ejemplares similares

Plasma Protein Growth Arrest–Specific 6 Levels Are Associated With Altered Glucose Tolerance, Inflammation, and Endothelial Dysfunction
por: Hung, Yi-Jen, et al.
Publicado: (2010)

Growth Arrest-Specific 6 Protein in Patients with Sjögren Syndrome: Determination of the Plasma Level and Expression in the Labial Salivary Gland
por: Chen, Chen-Hung, et al.
Publicado: (2015)

End-tidal Carbon Dioxide + Return of Spontaneous Circulation After Cardiac Arrest (RACA) Score to Predict Outcomes After Out-of-hospital Cardiac Arrest
por: Wu, Cheng-Yi, et al.
Publicado: (2023)

Erythropoietin prevents dementia in hemodialysis patients: a nationwide population-based study
por: Hung, Peir-Haur, et al.
Publicado: (2019)

Negative Relationship between Erythropoietin Dose and Blood Lead Level in Patients Undergoing Maintenance Hemodialysis
por: Huang, Wen-Hung, et al.
Publicado: (2016)

Erythropoietin-producing tubercle granuloma in a hemodialysis patient
por: Satoh, Minoru, et al.
Publicado: (2013)

Obesity may be erythropoietin dose-saving in hemodialysis patients
por: El-Kannishy, Ghada M., et al.
Publicado: (2018)

Erythropoietin treatment and the risk of hip fractures in hemodialysis patients
por: Suresh, Sukanya, et al.
Publicado: (2021)

Erythropoietin Use and the Risk of Stroke in Patients on Hemodialysis: A Retrospective Cohort Study in Taiwan
por: Hung, Peir‐Haur, et al.
Publicado: (2021)

Growth arrest‐specific 6 modulates adiponectin expression and insulin resistance in adipose tissue
por: Su, Sheng‐Chiang, et al.
Publicado: (2020)

Association Between Stroke Risk and Metformin Use in Hemodialysis Patients With Diabetes Mellitus: A Nested Case–Control Study
por: Chien, Li‐Nien, et al.
Publicado: (2017)

Comparison of Hemoglobin Levels Before and After Hemodialysis and Their Effects on Erythropoietin Dosing and Cost
por: Sagheb, Mohammad Mahdi, et al.
Publicado: (2016)

Predicting erythropoietin resistance in hemodialysis patients with type 2 diabetes
por: Schneider, Andreas, et al.
Publicado: (2013)

Skeletal muscle mass is associated with erythropoietin response in hemodialysis patients
por: Takata, Tomoaki, et al.
Publicado: (2021)

Erythropoietin Resistance Development in Hemodialysis Patients: The Role of Oxidative Stress
por: Joksimovic Jovic, Jovana, et al.
Publicado: (2022)

Predictors of iron versus erythropoietin responsiveness in anemic hemodialysis patients
por: Hildebrand, Sarah, et al.
Publicado: (2022)

Recombinant Erythropoietin in Humans Has a Prolonged Effect on Circulating Erythropoietin Isoform Distribution
por: Aachmann-Andersen, Niels Jacob, et al.
Publicado: (2014)

The Association of Erythropoietin and Age-Related Macular Degeneration in Hemodialysis Patients: A Nationwide Population-Based Cohort Study
por: Huang, Evelyn-Jou-Chen, et al.
Publicado: (2022)

Transforming growth factor-β1 decreases erythropoietin production through repressing hypoxia-inducible factor 2α in erythropoietin-producing cells
por: Shih, Hong-Mou, et al.
Publicado: (2021)

Plasma Concentrations Predict Aortic Expression of Growth-Arrest-Specific Protein 6 in Patients Undergoing Coronary Artery Bypass Grafting
por: Lee, Chien-Hsing, et al.
Publicado: (2013)

Growth arrest-specific gene 6 expression in human breast cancer
por: Mc Cormack, O, et al.
Publicado: (2008)

Effect of erythropoietin on level of circulating endothelial progenitor cells and outcome in patients after acute ischemic stroke
por: Yip, Hon-Kan, et al.
Publicado: (2011)

Intracerebral transplantation of erythropoietin‐producing fibroblasts facilitates neurogenesis and functional recovery in an ischemic stroke model
por: Chou, Pin‐Chun, et al.
Publicado: (2019)

Circulating microRNAs and vascular calcification in hemodialysis patients
por: Lee, Chien-Te, et al.
Publicado: (2019)

Oral Zinc Supplementation Reduces the Erythropoietin Responsiveness Index in Patients on Hemodialysis
por: Kobayashi, Hiroki, et al.
Publicado: (2015)

Gender Differences in Dose of Erythropoietin to Maintain Hemoglobin Target in Hemodialysis Patients
por: Coronado Daza, J. A., et al.
Publicado: (2019)

Comparing the effects of intravenous and subcutaneous Erythropoietin on blood indices in hemodialysis patients
por: Ghasemi, Faramarz, et al.
Publicado: (2019)

Gut Microbiota Correlates With Clinical Responsiveness to Erythropoietin in Hemodialysis Patients With Anemia
por: Zhu, Yifan, et al.
Publicado: (2022)

Correction: Plasma Concentrations Predict Aortic Expression of Growth-Arrest-Specific Protein 6 in Patients Undergoing Coronary Artery Bypass Grafting
por: Lee, Chien-Hsing, et al.
Publicado: (2017)

Correction of Anemia with Continuous Erythropoietin Receptor Activator in Korean Patients on Long-Term Hemodialysis
por: Oh, Jieun, et al.
Publicado: (2014)

Growth Arrest-Specific 6 in Chromophobe Renal Cell Carcinoma
por: Mikuteit, Marie, et al.
Publicado: (2022)

Roxadustat in the treatment of a hemodialysis patient with anti-erythropoietin antibody-mediated pure red cell aplasia
por: Xu, Bojun, et al.
Publicado: (2021)

Growth arrest-specific protein 6 (GAS6) and the protein C pathway
por: Li, Shi-Sheng
Publicado: (2007)

Growth Arrest-Specific 6 (Gas6) and TAM Receptors in Mouse Platelets
por: Uras, Fikriye, et al.
Publicado: (2015)

Trajectories of Vital Signs and Risk of In-Hospital Cardiac Arrest
por: Tsai, Chu-Lin, et al.
Publicado: (2022)

How the Duration Period of Erythropoietin Treatment Influences the Oxidative Status of Hemodialysis Patients
por: Dimitrijevic, Zorica M., et al.
Publicado: (2012)

Association of Erythropoietin-Stimulating Agent Responsiveness with Mortality in Hemodialysis and Peritoneal Dialysis Patients
por: Bae, Myoung Nam, et al.
Publicado: (2015)

Ergocalciferol treatment does Not improve erythropoietin utilization and hospitalization rate in hemodialysis patients
por: Agarwal, Gaurav, et al.
Publicado: (2016)

Pure red cell aplasia due to antibody against erythropoietin in hemodialysis patients
por: Rahbar, Maryam, et al.
Publicado: (2017)

Erythropoietin Dose and Mortality in Hemodialysis Patients: Marginal Structural Model to Examine Causality
por: Streja, Elani, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_4eg00r832pl87ri5d5f27a1isc